Lymphocyte counting recovery prediction model construction method and device and electronic equipment

Abstract

The invention provides a lymphocyte counting recovery prediction model construction method and device and electronic equipment, and relates to the technical field of cancer risk assessment, and the method comprises the steps: obtaining pre-radiotherapy clinical feature information and post-radiotherapy medical examination information of a training set object; classifying the training set objects based on the clinical feature information of the training set objects to obtain classification results of the training set objects; determining a progression-free life cycle value of the training set object based on the clinical feature information of the training set object; drawing a survival curve based on the classification result of the training set object and the progress-free life cycle value; and constructing a lymphocyte counting recovery prediction model based on the correlation value of the prediction factor. According to the method, the complementary effect of each independent factor of the patient can be comprehensively utilized, the recovery probability of the early NSCLC patient after the SBRT is accepted is quantitatively and accurately evaluated, the prediction effect of the survival condition of the NSCLC patient after the SBRT is accepted is improved, and close monitoring and additional treatment intervention are given to the high-risk patient in time.

Description

technical field [0001] The invention relates to the technical field of cancer risk assessment, in particular to a method, device and electronic device for constructing a lymphocyte count recovery prediction model. Background technique [0002] Primary bronchial lung cancer (lung cancer for short) is one of the malignant tumors with the highest morbidity and mortality in the world, seriously endangering human life safety and quality of life. Surgical resection is the standard treatment for patients with early-stage lung cancer who can tolerate surgery, but many patients cannot tolerate surgery due to advanced age, poor lung function, or other comorbidities. In recent years, with the development of radiotherapy technology and equipment, stereotactic body radiation therapy (SBRT, Stereotactic Body Radiation Therapy) has been gradually applied to the treatment of patients with early lung cancer and achieved good results. [0003] As an important part of the body's immune system...

AI Technical Summary

Problems solved by technology

SBRT can also cause the decrease of TLCs in patients with early lung cancer and affect the prognosis of lung cancer patients. However, it is still unclear when TLCs will recover after SBRT in patients with early lung cancer and whether the recovery of TLCs can improve the prognosis of patients.

Images